Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

ClinicalTrials.gov ID: NCT00629057

Public ClinicalTrials.gov record NCT00629057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 16, 2026, 10:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

Study identification

NCT ID
NCT00629057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Bavarian Nordic
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • MVA-BN-PRO Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2008
Primary completion
Nov 30, 2010
Completion
Aug 31, 2011
Last update posted
Mar 12, 2019

2008 – 2011

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307
Lawrenceville Urology Lawrenceville New Jersey 08648
Presbyterian Hospital Center for Cancer Research Charlotte North Carolina 28173
Urology Associates Nashville Tennessee
Urology Clinics of North Texas, PA Dallas Texas 75231
Urology Associates of South Texas McAllen Texas 78503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00629057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2019 · Synced Jun 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00629057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →